Stoessl AJ - Search Results

1

Parkinson's disease: in vivo assessment of disease progression using positron emission tomography.

Au WL, Adams JR, Troiano AR, Stoessl AJ. Au WL, et al. Among authors: stoessl aj. Brain Res Mol Brain Res. 2005 Mar 24;134(1):24-33. doi: 10.1016/j.molbrainres.2004.09.028. Epub 2004 Nov 2. Brain Res Mol Brain Res. 2005. PMID: 15790527 Review.

2

Neuroreceptor imaging: new developments in PET and SPECT imaging of neuroreceptor binding (including dopamine transporters, vesicle transporters and post synaptic receptor sites).

Stoessl AJ, Ruth TJ. Stoessl AJ, et al. Curr Opin Neurol. 1998 Aug;11(4):327-33. doi: 10.1097/00019052-199808000-00008. Curr Opin Neurol. 1998. PMID: 9725078 Review.

3

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.

Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ. Lee CS, et al. Among authors: stoessl aj. Ann Neurol. 2000 Apr;47(4):493-503. Ann Neurol. 2000. PMID: 10762161

4

Nigrostriatal dopamine system and motor lateralization.

de la Fuente-Fernández R, Kishore A, Calne DB, Ruth TJ, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: stoessl aj. Behav Brain Res. 2000 Jul;112(1-2):63-8. doi: 10.1016/s0166-4328(00)00165-0. Behav Brain Res. 2000. PMID: 10862936

5

Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.

de la Fuente-Fernández R, Lu JQ, Sossi V, Jivan S, Schulzer M, Holden JE, Lee CS, Ruth TJ, Calne DB, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: stoessl aj. Ann Neurol. 2001 Mar;49(3):298-303. doi: 10.1002/ana.65.abs. Ann Neurol. 2001. PMID: 11261503

6

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.

de la Fuente-Fernández R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: stoessl aj. Science. 2001 Aug 10;293(5532):1164-6. doi: 10.1126/science.1060937. Science. 2001. PMID: 11498597 Clinical Trial.

7

Neurochemical and neuroreceptor imaging with PET in Parkinson's disease.

Stoessl AJ. Stoessl AJ. Adv Neurol. 2001;86:215-23. Adv Neurol. 2001. PMID: 11553980 Review. No abstract available.

8

Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.

de La Fuente-Fernández R, Lim AS, Sossi V, Holden JE, Calne DB, Ruth TJ, Stoessl AJ. de La Fuente-Fernández R, et al. Among authors: stoessl aj. J Cereb Blood Flow Metab. 2001 Oct;21(10):1151-9. doi: 10.1097/00004647-200110000-00003. J Cereb Blood Flow Metab. 2001. PMID: 11598492

9

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.

Sossi V, de La Fuente-Fernández R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, Ruth TJ. Sossi V, et al. Among authors: stoessl aj. J Cereb Blood Flow Metab. 2002 Feb;22(2):232-9. doi: 10.1097/00004647-200202000-00011. J Cereb Blood Flow Metab. 2002. PMID: 11823721

10

The placebo effect in Parkinson's disease.

de la Fuente-Fernández R, Stoessl AJ. de la Fuente-Fernández R, et al. Among authors: stoessl aj. Trends Neurosci. 2002 Jun;25(6):302-6. doi: 10.1016/s0166-2236(02)02181-1. Trends Neurosci. 2002. PMID: 12086748 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters